Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+88.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+88.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 167.41% |
| 2024 | -177.92% |
| 2023 | -19.94% |
| 2022 | 25.18% |
| 2021 | -10.15% |
| 2020 | -45.04% |
| 2019 | -48.80% |
| 2018 | -17.47% |
| 2017 | 26.48% |
| 2016 | -27.64% |